(O-B4) The Association Between Sonographic Common Bile Duct Dilatation and Outcomes in Emergency Department Patients with Cholangitis

Objectives: To determine whether sonographic common bile duct (CBD) dilatation in emergency department (ED) patients with acute cholangitis (AC) predicts outcomes including sepsis, hospital length of stay (LOS), admission to the intensive care unit (ICU), time to ERCP, and mortality.

Background: The presentation of the patient with AC ranges from mild illness to life-threatening shock. Therefore, prompt diagnosis and treatment are critical. Abdominal ultrasound (US) is the imaging of choice to locate bile duct dilatation. Other modalities include abdominal computed tomography (CT) or endoscopic retrograde cholangiopancreatography (ERCP).

Methods: Electronic medical records of all patients hospitalized in a tertiary care medical center between July 2012- February 2021 with a discharge diagnosis of cholangitis were assessed. Patients were dichotomously classified as CBD dilated or CBD non-dilated based on ultrasound. Dilation was defined as CBD larger than 6 mm in patients younger than 60 or larger than 6 mm + 1 mm per decade in patients over 60.

Results: The study included 271 patients- 172 with CBD dilation versus 99 without. Mean LOS was 9.92 days for those with a dilated CBD versus 13.4 days without. The mean time to ERCP was 4.26 days for those with a dilated CBD versus 6.56 days without. Sepsis, mortality, and ICU admission were scarce and there was no statistically significant difference between the cohorts.

Conclusions: Patients with a dilated CBD per the abdominal US performed during the patient’s ED stay, underwent ERCP earlier, and were hospitalized fewer days than patients without CBD dilation.

References (Optional):

Funding (Optional): None